Literature DB >> 23358687

Is the simultaneously integrated boost (SIB) technique for early breast cancer ready to be adopted for routine adjuvant radiotherapy? Statement of the German and the Austrian Societies of Radiooncology (DEGRO/ÖGRO).

F Sedlmayer, M L Sautter-Bihl, W Budach, J Dunst, P Feyer, R Fietkau, W Haase, W Harms, C Rödel, R Souchon, F Wenz, R Sauer.   

Abstract

Entities:  

Mesh：

Year:  2013        PMID： 23358687     DOI： 10.1007/s00066-012-0300-3

Source DB:  PubMed          Journal:  Strahlenther Onkol        ISSN： 0179-7158            Impact factor:   3.621


× No keyword cloud information.
  23 in total

1.  The IMPORT trials are launched (September 2006).

Authors:  C Coles; J Yarnold
Journal:  Clin Oncol (R Coll Radiol)       Date:  2006-10       Impact factor: 4.126

2.  Comparative acute toxicity from whole breast irradiation using 3-week accelerated schedule with concomitant boost and the 6.5-week conventional schedule with sequential boost for early-stage breast cancer.

Authors:  Manjeet Chadha; Dan Vongtama; Patricia Friedmann; Celina Parris; Susan K Boolbol; Rudolph Woode; Louis B Harrison
Journal:  Clin Breast Cancer       Date:  2011-11-06       Impact factor: 3.225

3.  Simultaneous integrated boost irradiation after breast-conserving surgery: physician-rated toxicity and cosmetic outcome at 30 months' follow-up.

Authors:  Enja J Bantema-Joppe; Cornelis Schilstra; Geertruida H de Bock; Wil V Dolsma; Dianne M Busz; Johannes A Langendijk; John H Maduro
Journal:  Int J Radiat Oncol Biol Phys       Date:  2012-04-10       Impact factor: 7.038

4.  Fractionation sensitivity and dose response of late adverse effects in the breast after radiotherapy for early breast cancer: long-term results of a randomised trial.

Authors:  John Yarnold; Anita Ashton; Judith Bliss; Janis Homewood; Caroline Harper; Jane Hanson; Jo Haviland; Søren Bentzen; Roger Owen
Journal:  Radiother Oncol       Date:  2005-03-16       Impact factor: 6.280

5.  The influence of patient, tumor and treatment factors on the cosmetic results after breast-conserving therapy in the EORTC 'boost vs. no boost' trial. EORTC Radiotherapy and Breast Cancer Cooperative Groups.

Authors:  C Vrieling; L Collette; A Fourquet; W J Hoogenraad; J H Horiot; J J Jager; M Pierart; P M Poortmans; H Struikmans; B Maat; E Van Limbergen; H Bartelink
Journal:  Radiother Oncol       Date:  2000-06       Impact factor: 6.280

6.  Unacceptable cosmesis in a protocol investigating intensity-modulated radiotherapy with active breathing control for accelerated partial-breast irradiation.

Authors:  Reshma Jagsi; Merav A Ben-David; Jean M Moran; Robin B Marsh; Kent A Griffith; James A Hayman; Lori J Pierce
Journal:  Int J Radiat Oncol Biol Phys       Date:  2010-01-01       Impact factor: 7.038

7.  DEGRO practical guidelines for radiotherapy of breast cancer I: breast-conserving therapy.

Authors:  Marie-Luise Sautter-Bihl; Wilfried Budach; Jürgen Dunst; Petra Feyer; Wulf Haase; Wolfgang Harms; Felix Sedlmayer; Rainer Souchon; Frederik Wenz; Rolf Sauer
Journal:  Strahlenther Onkol       Date:  2007-12       Impact factor: 3.621

8.  Predictors of the risk of fibrosis at 10 years after breast conserving therapy for early breast cancer: a study based on the EORTC Trial 22881-10882 'boost versus no boost'.

Authors:  Sandra Collette; Laurence Collette; Tom Budiharto; Jean-Claude Horiot; Philip M Poortmans; Henk Struikmans; Walter Van den Bogaert; Alain Fourquet; Jos J Jager; Willem Hoogenraad; Rolf-Peter Mueller; John Kurtz; David A L Morgan; Jean-Bernard Dubois; Emile Salamon; Rene Mirimanoff; Michel Bolla; Marleen Van der Hulst; Carla C Wárlám-Rodenhuis; Harry Bartelink
Journal:  Eur J Cancer       Date:  2008-08-29       Impact factor: 9.162

9.  Five-year local control in a phase II study of hypofractionated intensity modulated radiation therapy with an incorporated boost for early stage breast cancer.

Authors:  Gary M Freedman; Penny R Anderson; Richard J Bleicher; Samuel Litwin; Tianyu Li; Ramona F Swaby; Chang-Ming Charlie Ma; Jinsheng Li; Elin R Sigurdson; Deborah Watkins-Bruner; Monica Morrow; Lori J Goldstein
Journal:  Int J Radiat Oncol Biol Phys       Date:  2012-05-12       Impact factor: 7.038

Review 10.  Relationship between irradiated breast volume and late normal tissue complications: a systematic review.

Authors:  Mukesh Mukesh; Emma Harris; Raj Jena; Philip Evans; Charlotte Coles
Journal:  Radiother Oncol       Date:  2012-06-08       Impact factor: 6.280
View more
  14 in total

1.  From heart to heart for breast cancer patients - cardiovascular toxicities in breast cancer radiotherapy.

Authors:  M N Duma; M Molls; K R Trott
Journal:  Strahlenther Onkol       Date:  2013-11-21       Impact factor: 3.621

2.  Design and implementation of a "cheese" phantom-based Tomotherapy TLD dose intercomparison.

Authors:  Hans Schiefer; Konrad Buchauer; Simon Heinze; Guido Henke; Ludwig Plasswilm
Journal:  Strahlenther Onkol       Date:  2015-06-19       Impact factor: 3.621

Review 3.  Tumor Bed Boost Integration during Whole Breast Radiotherapy: A Review of the Current Evidence.

Authors:  Pierfrancesco Franco; Domenico Cante; Piera Sciacero; Giuseppe Girelli; Maria Rosa La Porta; Umberto Ricardi
Journal:  Breast Care (Basel)       Date:  2015-02       Impact factor: 2.860

4.  Radiation oncologists' view on the zurich consensus.

Authors:  Rainer Souchon; Marie-Luise Sautter-Bihl; Felix Sedlmayer; Frederik Wenz; Wilfried Budach; Rolf Sauer
Journal:  Breast Care (Basel)       Date:  2013-12       Impact factor: 2.860

Review 5.  Recent Developments in Radiation Oncology: An Overview of Individualised Treatment Strategies in Breast Cancer.

Authors:  Montserrat Pazos; Stephan Schönecker; Daniel Reitz; Paul Rogowski; Maximilian Niyazi; Filippo Alongi; Christiane Matuschek; Michael Braun; Nadia Harbeck; Claus Belka; Stefanie Corradini
Journal:  Breast Care (Basel)       Date:  2018-05-24       Impact factor: 2.860

6.  Expert Discussion: Hypofractionated Radiation Therapy - Standard for All Indications?

Authors:  Gerd Fastner; David Krug; Icro Meattini; Günther Gruber; Philip Poortmans
Journal:  Breast Care (Basel)       Date:  2021-12-20       Impact factor: 2.268

7.  Hypofractionation with simultaneous integrated boost for early breast cancer: results of the German multicenter phase II trial (ARO-2010-01).

Authors:  Kathrin Dellas; Reinhard Vonthein; Jörg Zimmer; Stefan Dinges; Alexander D Boicev; Peter Andreas; Dorothea Fischer; Cornelia Winkler; Andreas Ziegler; Jürgen Dunst
Journal:  Strahlenther Onkol       Date:  2014-04-16       Impact factor: 3.621

8.  Dosimetric comparison of the simultaneous integrated boost in whole-breast irradiation after breast-conserving surgery: IMRT, IMRT plus an electron boost and VMAT.

Authors:  Sangang Wu; Youqun Lai; Zhenyu He; Yuan Zhou; Shanyu Chen; Mingming Dai; Juan Zhou; Qin Lin; Feng Chi
Journal:  PLoS One       Date:  2015-03-17       Impact factor: 3.240

9.  Comparison of breast simultaneous integrated boost (SIB) radiotherapy techniques.

Authors:  Moamen M O M Aly; Gerhard Glatting; Lennart Jahnke; Frederik Wenz; Yasser Abo-Madyan
Journal:  Radiat Oncol       Date:  2015-07-09       Impact factor: 3.481

10.  DEGRO practical guidelines: radiotherapy of breast cancer I: radiotherapy following breast conserving therapy for invasive breast cancer.

Authors:  F Sedlmayer; M-L Sautter-Bihl; W Budach; J Dunst; G Fastner; P Feyer; R Fietkau; W Haase; W Harms; R Souchon; F Wenz; R Sauer
Journal:  Strahlenther Onkol       Date:  2013-10       Impact factor: 3.621
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.